The US pharmaceutical sector is experiencing a distinct trend never seen before with large American pharma companies continually looking for medicines in China.

Discover how innovative physical therapy, smart medications, nutrition strategies and mind-body techniques are transforming ...

The U.S. Food and Drug Administration recently approved a new class of non-opioid painkiller which one Lowcountry pharmacist is calling “revolutionary.” ...

Tris Pharma’s first-in-class oral dual-NMR agonist achieved its primary endpoint in the ALLEVIATE-2 study by demonstrating a ...

The popular painkiller Advil has been increasingly targeting the running community, partnering with influencers to promote ...

Topline results were announced from a phase 3 trial evaluating cebranopadol for the treatment of moderate to severe acute pain in patients following ...

Tris Pharma previously announced data from another Phase III trial of cebranopadol, which also met its primary endpoint.

Tris Pharma, Inc. (Tris), a commercial-stage biopharmaceutical company, today announced positive topline results from its ...

Background/aim In baseball pitching, neuromuscular fatigue and its manifestations on muscle strength, muscle soreness and ...

A research team funded by the National Institutes of Health (NIH) has developed a medication that shows promise in treating acute and chronic pain. The drug, known as VIP36, targets the body’s ...

LTG-001, a selective inhibitor for treatment of acute pain, was granted Fast Track designation by the Food and Drug Administration (FDA).

The Vatican says Pope Francis is in stable condition and breathing with just the help of supplemental oxygen after respiratory crises a day earlier.